NUR 3145: PHARMACOLOGY EXAM 1 PART
1 (PRINCIPLES OF PHARMACOLOGY (CH. 1-
10), DRUG THERAPY ACROSS THE
LIFESPAN (CH. 11-13) LATEST QUESTIONS
WITH COMPLETE SOLUTIONS.
1 of 124
Term
What is a maintenance dose?
Give this one a try later!
eliminate concentration from the keep concentration within
body therapeutic range
reduce concentration to increase concentration to toxic
subtherapeutic range levels
, Don't know?
2 of 124
Term
What is dependence?
Give this one a try later!
dev over long-term use, body
adapts--abstinence immediate tolerance, no long-term
(withdrawals) syndrome if effects
stopped
body adapts quickly, no withdrawal temporary effect, no physical
symptoms adaptation
Don't know?
3 of 124
Term
What are immunomodulators?
Give this one a try later!
traditional drugs--treat bacterial conventional drugs--manage
infections chronic pain
, new drugs--target cardiovascular new drugs--target diseases of
diseases immune system or cancer
Don't know?
4 of 124
Term
What is the application of pharmacology for patient education?
Give this one a try later!
drug name & therapeutic category, dosage, schedule, route & technique for
administration, expected response & time to response, non-drug measures
to improve response, treatment duration, drug storage, major adverse
effects to watch for, drug-drug & drug-food interactions, who to call for
therapeutic failure, adverse reactions, & interactions
some require it for metabolization!!!
preadministration assessment, dosage & administration, promoting therapeutic
effects, minimizing adverse effects & interactions, making prn decisions,
evaluation response to medication, managing toxicity
high risk of birth defects and abortion, should not be used during pregnancy
Don't know?
5 of 124
, Term
What is the drug approval process?
Give this one a try later!
preclinical testing (2-10 yrs), clinical testing (1-5 yrs; I-III after marketed, full approval
of new drug application (NDA)), post-marketing testing (III)
clinical testing (1-5 yrs), preclinical testing (2-10 yrs; I-III before marketed,
conditional approval of new drug application (NDA)), post-approval monitoring
(IV)
clinical testing (2-10 yrs), preclinical testing (1-5 yrs; I-III before marketed,
provisional approval of new drug application (NDA)), post-approval surveillance
(II)
preclinical testing (1-5 yrs), clinical testing (2-10 yrs; I-III before marketed,
conditional approval of new drug application (NDA)), post-marketing
surveillance (IV)
Don't know?
6 of 124
Term
What is the C risk category for drugs for pregnancy?
Give this one a try later!
1 (PRINCIPLES OF PHARMACOLOGY (CH. 1-
10), DRUG THERAPY ACROSS THE
LIFESPAN (CH. 11-13) LATEST QUESTIONS
WITH COMPLETE SOLUTIONS.
1 of 124
Term
What is a maintenance dose?
Give this one a try later!
eliminate concentration from the keep concentration within
body therapeutic range
reduce concentration to increase concentration to toxic
subtherapeutic range levels
, Don't know?
2 of 124
Term
What is dependence?
Give this one a try later!
dev over long-term use, body
adapts--abstinence immediate tolerance, no long-term
(withdrawals) syndrome if effects
stopped
body adapts quickly, no withdrawal temporary effect, no physical
symptoms adaptation
Don't know?
3 of 124
Term
What are immunomodulators?
Give this one a try later!
traditional drugs--treat bacterial conventional drugs--manage
infections chronic pain
, new drugs--target cardiovascular new drugs--target diseases of
diseases immune system or cancer
Don't know?
4 of 124
Term
What is the application of pharmacology for patient education?
Give this one a try later!
drug name & therapeutic category, dosage, schedule, route & technique for
administration, expected response & time to response, non-drug measures
to improve response, treatment duration, drug storage, major adverse
effects to watch for, drug-drug & drug-food interactions, who to call for
therapeutic failure, adverse reactions, & interactions
some require it for metabolization!!!
preadministration assessment, dosage & administration, promoting therapeutic
effects, minimizing adverse effects & interactions, making prn decisions,
evaluation response to medication, managing toxicity
high risk of birth defects and abortion, should not be used during pregnancy
Don't know?
5 of 124
, Term
What is the drug approval process?
Give this one a try later!
preclinical testing (2-10 yrs), clinical testing (1-5 yrs; I-III after marketed, full approval
of new drug application (NDA)), post-marketing testing (III)
clinical testing (1-5 yrs), preclinical testing (2-10 yrs; I-III before marketed,
conditional approval of new drug application (NDA)), post-approval monitoring
(IV)
clinical testing (2-10 yrs), preclinical testing (1-5 yrs; I-III before marketed,
provisional approval of new drug application (NDA)), post-approval surveillance
(II)
preclinical testing (1-5 yrs), clinical testing (2-10 yrs; I-III before marketed,
conditional approval of new drug application (NDA)), post-marketing
surveillance (IV)
Don't know?
6 of 124
Term
What is the C risk category for drugs for pregnancy?
Give this one a try later!
